Olivier Alain Lazzari

Title: Olivier Alain Lazzari: Innovator in Dopamine Agonist Research

Introduction

Olivier Alain Lazzari is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmacology, particularly in the development of novel compounds. His work focuses on dopamine agonists, which play a crucial role in treating various neurological conditions.

Latest Patents

Lazzari holds a patent for a salt form of a dopamine agonist, specifically 5-[(2R,5S)-5-methyl-4-propylmorpholin-2-yl]pyridin-2-amine. This invention pertains to the di-(1S)-camphorsulfonate form of this compound, known as di-S-camsylate. The patent details processes for the preparation of this salt, intermediates used in its synthesis, and its potential applications in therapeutic compositions.

Career Highlights

Olivier Alain Lazzari is associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to innovative research and development in the pharmaceutical industry. Lazzari's expertise in dopamine agonists has positioned him as a key figure in this area of study.

Collaborations

Throughout his career, Lazzari has collaborated with esteemed colleagues, including Stuart Peter Green and Duncan Charles Miller. These collaborations have fostered a productive environment for research and innovation in the field of pharmacology.

Conclusion

Olivier Alain Lazzari's contributions to the development of dopamine agonists highlight his role as an influential inventor in the pharmaceutical industry. His patent for a novel salt form of a dopamine agonist demonstrates his commitment to advancing medical science.